Re: USPTO: '749 Amendment Req Reconsideration After Non Final Rejection 1-19-10

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

DesignGuy

Rank: President [?]

Points: 1726 [?]

Votes: 42 Score: 3.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: USPTO: '749 Amendment Req Reconsideration After Non Final Rejection 1-19-10

in response to

Re: USPTO: '749 Amendment Req Reconsideration After Non Final Rejection 1-19-10

BostonCA

posted on Jan 21, 2010 07:19AM

IMO, the amended claims appear to be minor clarifications of earlier claims, i.e., no substantial changes have occured to their meaning. I interpret this as good news. We will now have to wait for the examiner to respond. Hopefully a NIRC is lurking around the corner.